Topics

Latest DNA sequencing NewsRSS

17:21 EDT 21st September 2019 | BioPortfolio

The upstart direct-to-consumer DNA-testing company Nebula Genomics announced that it will offer anonymous genome sequencing, becoming the first to do so amid public concerns about the privacy of genetic data. https://buff.ly/2OeSRfW 

The upstart direct-to-consumer DNA-testing company Nebula Genomics announced that it will offer anonymous genome sequencing, becoming the first to do so amid public concerns about the privacy of genetic data. https://buff.ly/2OeSRfW 

KemPharm Provides Updates Regarding its Board of Directors

CELEBRATION, Fla., Sept. 20, 2019 (GLOBE NEWSWIRE) — KemPharm, Inc. (Nasdaq: KMPH), a specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs, announced today that, on September 18, 2019, Danny L. Thompson provided notice of his resignation from … Continue reading →

Novo's Tresiba Misses Comparison Mark to Sanofi's Toujeo http://dlvr.it/RDXT9Z pic.twitter.com/vGBjemJEp7

Novo's Tresiba Misses Comparison Mark to Sanofi's Toujeo http://dlvr.it/RDXT9Z  pic.twitter.com/vGBjemJEp7

An arms race in drug development? AI demonstrates ‘true power’ to accelerate research

Insilico Medicine brings in $37m to further develop its artificial intelligence work after publishing a study that demonstrates the âreal-world potentialâ of AI for drug discovery â moving the idea from theory to reality.

Novo Nordisk's Rybelsus gains FDA approval as first oral GLP-1 receptor agonist for type 2 diabetes https://www.firstwordpharma.com/node/1668012  $NVO

Novo Nordisk's Rybelsus gains FDA approval as first oral GLP-1 receptor agonist for type 2 diabetes https://www.firstwordpharma.com/node/1668012  $NVO

Novo gains approval for first oral diabetes drug of its kind

The list price for Rybelsus will be competitive within the GLP-1 drug class, Novo said, which may make it more expensive than other glucose-lowering pills.

As Pharma Reaches for Precision Medicine, Instrument Makers Follow

Strategic Directions International shares insights from recent market report on Lab Instrumentation Markets for Pharmaceuticals, Biopharmaceuticals, & CROs. LOS ANGELES (PRWEB) September 20, 2019 A new report from Strategic Directions International (SDi) says that instrument makers are adjusting to client demands for precision medicine products. The report, Lab Instrumentation Markets for Pha...

INanoBio to Receive Up to $5.4 Million to Develop an Epigenetic Sequencer for Detecting WMD Exposures

INanoBio, a startup developing early stage disease diagnostics by combining semiconductor nanotechnology with biotechnology and machine learning, to receive up to $5.4 Million over four years as part of the Defense Advanced Research Projects Agency (DARPA) contract worth up to $27.8 Million awarded to consortium led by the Icahn School of Medicine at Mount Sinai New York. DARPA is a research agen...

Batavia Biosciences to deploy Horizon Discovery’s CHO cell technology to develop anti-Zika biotherapeutics

Batavia Biosciences has signed a license agreement to utilize Horizon Discovery’s GS knockout CHO K1 cell line expression system for the development of high yield antibody-expressing cell lines. Initially, Batavia will deploy the system for production of a potent Zika virus neutralizing antibody, working in collaboration with Vanderbilt University Medical Center and IDBiologics...

Novo's Tresiba Misses Comparison Mark to Sanofi's Toujeo

While the Danish drugmaker’s Tresiba (insulin degludec) didn’t fare as well as hoped in the head-to-head trial, Novo Nordisk was quick to point out that Tresiba showed an overall lower risk of hypoglycemia compared to Toujeo.

Practical Dosing Considerations for Venetoclax

With FDA-approved indications for both chronic lymphocytic leukemia and acute myeloid leukemia, and continued investigation within multiple disease states, venetoclax has become an exciting oral targeted therapy among oncologists. 

Global Immune Repertoire Sequencing Market Size study, by Type Assay Kits, Software Services, by Application Biomarker Discovery, Infectious Diseases, Vaccine Development Efficacy, Cancer Immunotherapy, Autoimmune Diseases, Transplant Rejection Toleran

Global Immune Repertoire Sequencing Market to reach USD XX billion by 2025.Global Immune Repertoire Sequencing Market valued approximately USD XX billion in 2017 is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 20182025. Immune repertoire is subtype of proteins on organism's immune system creates. Immune repertoire sequencing allows scientist and research...

Amid privacy concerns, startup becomes first consumer DNA company to offer anonymous sequencing

Nebula will offer anonymous testing amid public concerns about the privacy of genetic data and law enforcement use of public DNA databases to identify suspects.

Nebula Genomics Launches Anonymous Genetic Testing

Calls for adoption of privacy-preserving technologies by direct-to-consumer personal genomics companies Nebula Genomics, a privacy-focused personal genomics company, has launched a new privacy-preserving feature - anonymous genetic testing. Nebula Genomics customers will now be able to purchase whole-genome sequencing, submit their sample, and receive their results without having to reveal any i...

Celsius Therapeutics Signs Multiple Agreements with Academic Institutions to Access Samples for the Identification of Novel Targets in Immune Checkpoint Therapy Resistance

Celsius Applying its Single-Cell Genomics Platform Across Multiple Tumor Types and Immuno-Oncology Clinical Trials Celsius Therapeutics, a company focused on bringing personalized medicine to patients with cancer, autoimmunity and other complex diseases, today announced the signing of collaboration agreements with the Parker Institute for Cancer Immunotherapy (San Francisco, USA), Institut Gusta...

Toyobo to market RNA Analysis Kit based on RIKEN technology to help develop genomic medicine

OSAKA, Japan, Sept. 18, 2019 /PRNewswire/ -- Toyobo Co., Ltd. has productized a ribonucleic acid (RNA) analysis kit based on a novel system titled RamDA-seq™*1, that allows full-length sequencing of the total RNA of a single cell. The Laboratory for Bioinformatics Research at the RIKEN Center for Biosystems Dynamics Research developed this method last year. As national health insurance pro...

GenomSys, the Swiss Startup Disrupting Genomics Information Handling, Closes a CHF 9.3 Million Series A Investment Round

GenomSys, a software company developing ISO compliant technology for efficient processing and sharing of DNA data, announced it has completed its series A investment round. The company raised CHF 9.3 million in this financing, driven by the accelerating development progress of its MPEG-G-based solution for DNA data processing. The Series A round was led by Preon Capital, the Geneva-based family...

Bacterial Structures Might Be Used for Human Drug Delivery

Metamorphosis Associated Contractile structures (MACs) discovered by San Diego State University, inject a protein into animal cells that leads to metamorphosis. It may also be in the human gut and could be tapped to deliver targeted drugs in the future. The post Bacterial Structures Might Be Used for Human Drug Delivery appeared first on GEN - Genetic Engineering and Biotechnology News.

Li-Fraumeni syndrome: not a straightforward diagnosis anymore—the interpretation of pathogenic variants of low allele frequency and the differences between germline PVs, mosaicism, and clonal hematopoiesis

The introduction of next-generation sequencing has resulted in testing multiple genes simultaneously to identify inherited pathogenic variants (PVs) in cancer susceptibility genes. PVs with low minor allele fr...

Ozempic® Offers Superior Reductions in HbA1c and Body Weight Compared to Both Victoza® and Canagliflozin in People With Type 2 Diabetes

BAGSVÆRD, Denmark, Sept. 17, 2019 /PRNewswire/ -- Novo Nordisk announced today the results from two Ozempic® (once-weekly semaglutide 1.0 mg) head-to-head Phase 3 clinical trials, SUSTAIN 8 and SUSTAIN 10, which showed: Ozempic® was superior to treatment with the SGLT-2 inhibitor canagliflozin (300 mg) in reducing HbA1c and body weight in people with type 2 diabete...

Medtronic, Novo Nordisk collaborate on integrated digital solutions for diabetes

Irish medical device company Medtronic and Danish multinational pharmaceutical company Novo Nordisk have entered into a collaboration to develop solutions based on insulin dosing data and smart insulin The post Medtronic, Novo Nordisk collaborate on integrated digital solutions for diabetes appeared first on NS Medical Devices.

Oral semaglutide improves glycaemic control in people with type 2 diabetes across baseline blood sugar levels

BARCELONA, Spain, Sept. 17, 2019 /PRNewswire/ -- Novo Nordisk today announced findings from an exploratory analysis of the PIONEER trial programme, showing oral semaglutide (3, 7 and 14 mg) improved glycaemic control in people with type 2 diabetes across baseline HbA1c levels. Greater reductions in HbA1c were demonstrated with 7 mg and 14 mg oral semaglutide vs all comparators including place...

Emerging Biomarkers for Targeted Agents Show Promise in NSCLC

Alex A. Adjei, MD, PhD, a professor of oncology and pharmacology at Mayo Clinic, discussed the history of five target genes: NTRK, RET, MET, BRAF, and HER2, as well as the exciting data coming out for the lung cancer subset.

O2h to do ‘heavy lifting’ as part of synthetic chemistry collaboration with Cedilla

Cedilla Therapeutics and o2h Discovery have announced a multi full-time-equivalent (FTE) expansion to their synthetic chemistry collaboration.

LunaPBC, Medfusion Partner to Launch EHR Integration to Advance Scientific Discovery

– LunaPBC now enables members to access their electronic health records (EHRs) in the LunaDNA platform via Medfusion’s Patient Data Application Program Interfaces (APIs). – Individuals can now leverage Medfusion’s national health data network to consolidate their health records and help drive discovery through private, secure data sharing LunaPBC — founder of LunaDNA, the first ....

Quick Search

review and buy DNA sequencing market research data and corporate reports here